Stratec SE (STSEY)
- Previous Close
6.70 - Open
6.70 - Bid --
- Ask --
- Day's Range
6.70 - 6.70 - 52 Week Range
6.70 - 26.25 - Volume
350 - Avg. Volume
0 - Market Cap (intraday)
424.481M - Beta (5Y Monthly) 0.44
- PE Ratio (TTM)
30.82 - EPS (TTM)
0.17 - Earnings Date May 30, 2025
- Forward Dividend & Yield 0.12 (1.77%)
- Ex-Dividend Date Jul 1, 2025
- 1y Target Est
--
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
www.stratec.comRecent News: STSEY
View morePerformance Overview: STSEY
Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare to: STSEY
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: STSEY
View moreValuation Measures
Market Cap
389.99M
Enterprise Value
483.06M
Trailing P/E
39.66
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.58
Price/Book (mrq)
1.74
Enterprise Value/Revenue
2.07
Enterprise Value/EBITDA
13.61
Financial Highlights
Profitability and Income Statement
Profit Margin
6.22%
Return on Assets (ttm)
3.98%
Return on Equity (ttm)
6.68%
Revenue (ttm)
257.62M
Net Income Avi to Common (ttm)
16.02M
Diluted EPS (ttm)
0.17
Balance Sheet and Cash Flow
Total Cash (mrq)
47.16M
Total Debt/Equity (mrq)
53.82%
Levered Free Cash Flow (ttm)
36.23M